Presentation

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Presenter: Ron Waksman

October 31, 2017

REGISTER for free or LOG IN to view this content

TCT 14: Safety and Clinical Performance of the Drug-Eluting Absorbable Metal Scaffold in the Treatment of Subjects With De Novo Lesions in Native Coronary Arteries at 12-Month Follow-up - BIOSOLVE-II and BIOSOLVE-III

Coronary

Presentation

TCT 2017

DES/BRS/DCB

Up Next

Presentation

TCT 93: Stent-Based Tissue Drug and Binding Target Protein Distributions - Durable vs Deployable Coatings

Presenter: Abraham Tzafriri, MD

October 31, 2017

More slides +

Presentation

TCT 5: Complete vs Culprit Only Lesion Intervention in ACS Patients With Multivessel Disease - Incidence and Outcomes From The London Heart Attack Group

Presenter: Krishnaraj Rathod, MD

October 31, 2017

Presentation

TCT 83: Provisional vs Planned Two-Stent Technique in Patients With Distal Bifurcation Left Main Disease Undergoing PCI: The EXCEL Trial

Presenter: David E. Kandzari

October 31, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.